Safety and efficacy of erlotinib in first-relapse glioblastoma: a phase II open-label study
Yung, W.K. Alfred, Vredenburgh, James J., Cloughesy, Timothy F., Nghiemphu, Phioanh, Klencke, Barbara, Gilbert, Mark R., Reardon, David A., Prados, Michael D.
Published in Neuro-oncology (Charlottesville, Va.) (01.10.2010)
Published in Neuro-oncology (Charlottesville, Va.) (01.10.2010)
Get full text
Journal Article
5020 Pharmacokinetics (PK), safety, and efficacy of trastuzumab (T)-DM1, a HER2 antibody-drug conjugate (ADC), in patients with HER2+ metastatic breast cancer (MBC): phase I and phase II trial results
Burris, H, Vukelja, S, Krop, I, Modi, S, Klencke, B, Girish, S, Sliwkowski, M.X, Dresser, M, Phillips, G.L, Rugo, H
Published in European journal of cancer supplements (2009)
Published in European journal of cancer supplements (2009)
Get full text
Journal Article
Oral eniluracil/5-fluorouracil in patients with inoperable hepatocellular carcinoma
Benson III, A. B., Mitchell, E., Abramson, N., Klencke, B., Ritch, P., Burnham, J. P., McGuirt, C., Bonny, T., Levin, J., Hohneker, J.
Published in Annals of oncology (01.04.2002)
Published in Annals of oncology (01.04.2002)
Get full text
Journal Article
Lugano 2014 criteria for assessing FDG-PET/CT in lymphoma: an operational approach for clinical trials
Van Heertum, Ronald L, Scarimbolo, Robert, Wolodzko, John G, Klencke, Barbara, Messmann, Richard, Tunc, Feza, Sokol, Levi, Agarwal, Rajan, Strafaci, James A, O'Neal, Michael
Published in Drug design, development and therapy (01.01.2017)
Published in Drug design, development and therapy (01.01.2017)
Get full text
Journal Article
Encapsulated plasmid DNA treatment for human papillomavirus 16-associated anal dysplasia: A Phase I study of ZYC101
KLENCKE, Barbara, MATIJEVIC, Mark, JAY, Naomi, DA COSTA, Maria, PALEFSKY, Joel M, URBAN, Robert G, LATHEY, Janet L, HEDLEY, Mary Lynne, BERRY, Michael, THATCHER, Joe, WEINBERG, Vivian, WILSON, Jennifer, DARRAGH, Teresa
Published in Clinical cancer research (01.05.2002)
Get full text
Published in Clinical cancer research (01.05.2002)
Journal Article
Improved Transfusion Independence Rates for Momelotinib versus Ruxolitinib in Anaemic Jaki Naive Myelofibrosis Patients Independent of Baseline Platelet or Transfusion Status
Kiladjian, JJ, Platzbecker, U, Mayer, J, Illes, A, Prejzner, W, Wozny, T, Vannucchi, AM, Kirgner, I, Nagy, Z, Grosicki, S, Derolf, A, Lazaroiu, MC, Yoon, SS, Goh, YT, Von Bubnoff, N, Verstovsek, S, Strouse, B, Klencke, B, Donahue, R, Mesa, R
Published in BRITISH JOURNAL OF HAEMATOLOGY (2022)
Get full text
Published in BRITISH JOURNAL OF HAEMATOLOGY (2022)
Conference Proceeding
Azacitidine Induces Demethylation of the Epstein-Barr Virus Genome in Tumors
CHAN, Anthony T. C, QIAN TAO, ROBERTSON, Keith D, FLINN, Ian W, MANN, Risa B, KLENCKE, Barbara, WING HONG KWAN, LEUNG, Thomas Wai-Tong, JOHNSON, Philip J, AMBINDER, Richard F
Published in Journal of clinical oncology (15.04.2004)
Published in Journal of clinical oncology (15.04.2004)
Get full text
Journal Article
The significance of pretreatment CD4 count on the outcome and treatment tolerance of HIV-positive patients with anal cancer
Hoffman, Rex, Welton, Mark L, Klencke, Barbara, Weinberg, Vivian, Krieg, Richard
Published in International journal of radiation oncology, biology, physics (01.04.1999)
Published in International journal of radiation oncology, biology, physics (01.04.1999)
Get full text
Journal Article
SABRE-B: a randomized phase II trial evaluating the safety and efficacy of combining sunitinib (S) with paclitaxel (P) + bevacizumab (B) as first-line treatment for HER2-negative metastatic breast cancer (MBC): final results
Mayer, E, Kozloff, M, Qamar, R, Klencke, B, Balkissoon, J, Parmar, H, Samant, M, Burstein, HJ
Published in Cancer research (Chicago, Ill.) (15.01.2009)
Published in Cancer research (Chicago, Ill.) (15.01.2009)
Get full text
Journal Article
Quantitative assessment of HER2 status and correlation with efficacy for patients (pts) with metastatic breast cancer (MBC) in a phase II study of trastuzumab-DM1 (T-DM1)
Krop, I. E., Burris, H. A., Rugo, H., O'Shaughnessy, J., Vogel, C. L., Amler, L., Strauss, A., Wong, E. K., Klencke, B., Pippen, J.
Published in Journal of clinical oncology (20.05.2009)
Published in Journal of clinical oncology (20.05.2009)
Get full text
Journal Article
A phase II study of trastuzumab-DM1 (T-DM1), a HER2 antibody-drug conjugate (ADC), in patients (pts) with HER2+ metastatic breast cancer (MBC): Final results
Vogel, C. L., Burris, H. A., Limentani, S., Borson, R., O'Shaughnessy, J., Vukelja, S., Agresta, S., Klencke, B., Birkner, M., Rugo, H.
Published in Journal of clinical oncology (20.05.2009)
Published in Journal of clinical oncology (20.05.2009)
Get full text
Journal Article
A phase II study of trastuzumab-DM1, a first-in-class HER2 antibody-drug conjugate, in patients with HER2+ metastatic breast cancer
Vukelja, S, Rugo, H, Vogel, C, Borson, R, Tan-Chiu, E, Birkner, M, Holden, SN, Klencke, B, O'Shaughnessy, J, Burris, HA
Published in Cancer research (Chicago, Ill.) (15.01.2009)
Published in Cancer research (Chicago, Ill.) (15.01.2009)
Get full text
Journal Article
Clinical pharmacokinetics of erlotinib (E) in glioblastoma multiforme (GBM) patients and its implication for dosing
Lu, J., Eppler, S., Ling, J., Prados, M., Klencke, B., Lum, B.
Published in Journal of clinical oncology (20.06.2006)
Published in Journal of clinical oncology (20.06.2006)
Get full text
Journal Article
Independent review of E2100 progression-free survival (PFS) with the addition of bevacizumab (B) to paclitaxel (P) as initial chemotherapy for metastatic breast cancer (MBC)
Klencke, B. J., Bhattacharya, S., Samant, M. K., Gralow, J. R., Dickler, M. N., Cobleigh, M. A., Perez, E. A., Shenkier, T. N., Davidson, N. E., Miller, K. D.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article
The restricted cellular host range of human herpesvirus 8
BLACKBOURN, D. J, LENNETTE, E, HERNDIER, B, LEVY, J. A, KLENCKE, B, MOSES, A, CHANDRAN, B, WEINSTEIN, M, GLOGAU, R. G, WITTE, M. H, WAY, D. L, KUTZKEY, T
Published in AIDS (London) (16.06.2000)
Published in AIDS (London) (16.06.2000)
Get full text
Journal Article
Improved transfusion independence rates for momelotinib versus ruxolitinib in anemic JAKi naïve myelofibrosis patients independent of baseline platelet or transfusion status
Kiladjian, Jean-Jacques, Platzbecker, Uwe, Mayer, Jiří, Illés, Árpád, Prejzner, Witold, Woźny, Tomasz, Tzvetkov, Nikolay, Vannucchi, Alessandro M., Kirgner, Ilya, Nagy, Zsolt, Grosicki, Sebastian, Derolf, Åsa, Lazaroiu, Mihaela Cornelia, Yoon, Sung-Soo, Goh, Yeow Tee, von Bubnoff, Nikolas, Verstovsek, Srdan, Klencke, Barbara J., Donahue, Rafe, Mesa, Ruben A.
Published in JOURNAL OF CLINICAL ONCOLOGY (20.05.2021)
Published in JOURNAL OF CLINICAL ONCOLOGY (20.05.2021)
Get full text
Journal Article
Conference Proceeding
Phase II study of erlotinib in recurrent GBM: Molecular predictors of outcome
Cloughesy, T., Yung, A., Vrendenberg, J., Aldape, K., Eberhard, D., Prados, M., Vandenberg, S., Klencke, B., Mischel, P.
Published in Journal of clinical oncology (01.06.2005)
Published in Journal of clinical oncology (01.06.2005)
Get full text
Journal Article
Erlotinib HCL for glioblastoma multiforme in first relapse, a phase II trial
Yung, A., Vredenburgh, J., Cloughesy, T., Klencke, B. J., Mischel, P. S., Bigner, D. D., Aldape, K., Vanderburg, S., Prados, M.
Published in Journal of clinical oncology (15.07.2004)
Published in Journal of clinical oncology (15.07.2004)
Get full text
Journal Article
Erlotinib HCL for glioblastoma multiforme in first relapse, a phase II trial
Yung, A., Vredenburgh, J., Cloughesy, T., Klencke, B. J., Mischel, P. S., Bigner, D. D., Aldape, K., Vanderburg, S., Prados, M.
Published in Journal of clinical oncology (15.07.2004)
Published in Journal of clinical oncology (15.07.2004)
Get full text
Journal Article